The Role of Molecular Imaging in Personalised Healthcare

Authors

  • Jason P. Holland Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. jason.holland@chem.uzh.ch

DOI:

https://doi.org/10.2533/chimia.2016.787

Keywords:

Cancer, Molecular imaging, Oncogenic signalling, Personalised medicine, Pet

Abstract

Functional molecular imaging provides a unique perspective on a disease. Methods including positron-emission tomography and magnetic resonance imaging allow us to interrogate spatial and temporal changes in biomarkers as well as probe the underlying biochemistry. When imaging is combined with molecular diagnostic tools, opportunities arise for measuring aberrant cellular signalling pathways with unprecedented detail. This brief commentary illustrates how radiotracers and nuclear imaging methods are being developed to monitor drug efficacy and simultaneously support the goal of personalised healthcare.

Downloads

Published

2016-11-30

How to Cite

[1]
J. P. Holland, Chimia 2016, 70, 787, DOI: 10.2533/chimia.2016.787.

Issue

Section

Scientific Articles